Kepler Capital Markets set a €119.00 ($141.67) price objective on Merck KGaA (FRA:MRK) in a report issued on Thursday, September 21st. The firm currently has a buy rating on the healthcare company’s stock.
MRK has been the subject of a number of other reports. HSBC Holdings plc set a €94.00 ($111.90) target price on shares of Merck KGaA and gave the stock a neutral rating in a research note on Wednesday, August 9th. Independent Research GmbH set a €105.00 ($125.00) price target on shares of Merck KGaA and gave the stock a neutral rating in a research report on Wednesday, September 6th. Berenberg Bank set a €116.00 ($138.10) price target on shares of Merck KGaA and gave the stock a buy rating in a research report on Tuesday, September 19th. Warburg Research set a €116.00 ($138.10) price target on shares of Merck KGaA and gave the stock a neutral rating in a research report on Tuesday, June 20th. Finally, Deutsche Bank AG set a €106.00 ($126.19) price target on shares of Merck KGaA and gave the stock a neutral rating in a research report on Wednesday, July 26th. Thirteen investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The company currently has an average rating of Hold and a consensus price target of €109.61 ($130.49).
Merck KGaA (MRK) opened at 94.60 on Thursday. The stock’s 50 day moving average price is €93.46 and its 200 day moving average price is €102.32. The stock has a market capitalization of €41.13 billion and a price-to-earnings ratio of 24.66. Merck KGaA has a 52-week low of €89.00 and a 52-week high of €115.00.
TRADEMARK VIOLATION WARNING: “Merck KGaA (FRA:MRK) Given a €119.00 Price Target by Kepler Capital Markets Analysts” was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://ledgergazette.com/2017/10/01/kepler-capital-markets-analysts-give-merck-kgaa-mrk-a-119-00-price-target.html.
Merck KGaA Company Profile
Receive News & Ratings for Merck KGaA Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Merck KGaA and related companies with MarketBeat.com’s FREE daily email newsletter.